<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00457756</url>
  </required_header>
  <id_info>
    <org_study_id>BiosLife 2005-4</org_study_id>
    <nct_id>NCT00457756</nct_id>
  </id_info>
  <brief_title>The Effect of BiosLife on Serum Lipids</brief_title>
  <official_title>The Effect of an Integrative Dietary Supplement on the Lipid Profile of Subjects With Hypercholesterolemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unicity International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double-blind, placebo-controlled study to assess the effectiveness of BiosLife in
      lowering serum LDL cholesterol and raising HDL cholesterol. BiosLife is a natural supplement
      (mixed in water and taken twice daily) which contains guar gum and other natural soluble
      fibers, phytosterols, policosanol, and a proprietary chrysanthemum extract. Approximately 100
      subjects with baseline LDL cholesterol of 110-190 mg/dL will be randomized in a 2:1 ratio to
      BiosLife or a look-alike placebo. Changes in lipids from baseline will be assessed at 6 weeks
      and 12 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>triglycerides</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL particle number</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL particle size distribution</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL particle number</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL particle size distribution</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VLDL particle number</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cohort I subjects will take supplement for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Cohort II will take placebo for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>BiosLife Complete</intervention_name>
    <arm_group_label>I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  LDL-C 110 - 190 mg/dL

          -  For current lipid-lowering prescription therapy users, the dose of lipid-lowering
             medication must have been constant for 3 months with no current plan for change in
             dose.

          -  Age 18 - 85 years

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Severe hypertension, defined as at least 180 / 100 mmHg

          -  Any other health condition that may interfere with the study results, as judged by the
             principle investigator

          -  Allergy against any of the ingredients in the tested product

          -  Any medical condition, in which fiber consumption is contraindicated (e.g. Crohn's
             disease

          -  The use of nutritional supplements during the last two months containing one or more
             similar ingredients, as the tested supplement.

          -  History of alcohol or drug abuse, psychological or other mental issues that are likely
             to invalidate informed consent, or limit the ability of the patient to comply with the
             protocol requirements

          -  Participation in any other studies involving investigational or marketed product
             concomitantly or within one month prior to entry into the study

          -  Pregnant or breast feeding

          -  Persons who eat only 1 meal per day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul N Hopkins, MD, MSPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Genetics, University of Utah, 420 Chipeta Way, Room 1160</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2007</study_first_submitted>
  <study_first_submitted_qc>April 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2007</study_first_posted>
  <last_update_submitted>May 5, 2008</last_update_submitted>
  <last_update_submitted_qc>May 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Paul Hopkins, MD, MSPH</name_title>
    <organization>University of Utah</organization>
  </responsible_party>
  <keyword>LDL cholesterol</keyword>
  <keyword>HDL cholesterol</keyword>
  <keyword>natural supplement</keyword>
  <keyword>guar gum</keyword>
  <keyword>phytosterols</keyword>
  <keyword>policosanol</keyword>
  <keyword>chrysanthemum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

